tiprankstipranks
Vera Therapeutics (VERA)
NASDAQ:VERA
US Market

Vera Therapeutics (VERA) Income Statement

Compare
390 Followers

Vera Therapeutics Income Statement

Last quarter (Q3 2024), Vera Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Vera Therapeutics's net income was $-46.63M. See Vera Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.86M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 1.86M$ 846.00K$ -176.00K$ -251.00K$ -509.00K
Operating Expenses
$ 102.01M$ 90.90M$ 34.40M$ 49.24M$ 11.70M
Depreciation and Amortization
$ 0.00$ -846.00K$ 176.00K$ 251.00K$ 509.00K
EBITDA
$ -102.01M$ -90.90M$ -34.23M$ -52.99M$ -11.19M
Operating Income
$ -102.01M$ -90.90M$ -34.40M$ -52.24M$ -11.96M
Other Income/Expenses
$ 6.02M$ 1.85M$ 1.79M$ -1.17M$ 108.00K
Pretax Income
$ -95.99M$ -89.06M$ -32.61M$ -53.41M$ -11.85M
Net Income
$ -95.99M$ -89.06M$ -32.61M$ -53.41M$ -11.85M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.25$ -3.35$ -1.53$ -14.40$ -3.46
Diluted EPS
$ -2.25$ -3.35$ -1.53$ -14.40$ -3.46
Weighted Average Shares Outstanding
42.71M 26.57M 21.28M 3.71M 3.42M
Weighted Average Shares Outstanding (Diluted)
42.71M 26.57M 21.28M 3.71M 3.42M
Currency in USD

Vera Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis